Nordwand Advisors »

Mersana Therapeutics shares owned by Nordwand Advisors

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Nordwand Advisors from 13F filings

Historical chart of Nordwand Advisors investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Nordwand Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Nordwand Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.8k 1.5k 1.89
2024-06-30 $3.0k 1.5k 2.01

More positions owned by Nordwand Advisors

Berkshire Hathaway Inc Del Cl A (BRK.A)
Johnson & Johnson (JNJ)
Novocure Ord Shs (NVCR)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded F Income Etf (JPIE)
Grab Holdings Class A Ord (GRAB)
Harbor Etf Trust Internatnal Comp (OSEA)
Ardagh Metal Packaging S A SHS (AMBP)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Mp Materials Corp Com Cl A (MP)
Oaktree Specialty Lending Corp (OCSL)
Series Portfolios Tr Panagram Bbb B (CLOZ)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for Nordwand Advisors

Top funds holding Mersana Therapeutics

EcoR1 Capital
Nextech Invest
VR Adviser
Bain Capital Life Sciences Investors
BlackRock
BlackRock
Vanguard Group
Citadel Advisors
Rock Springs Capital Management
State Street Corporation
Cormorant Asset Management
Silverarc Capital Management
Geode Capital Management
Jpmorgan Chase & Co
Morgan Stanley

View all funds holding Mersana Therapeutics